Christopher Thomas Giordano

Director & CEO

Director & CEO at TENAX THERAPEUTICS, INC., filing insider transactions between 2026-09-11 and 2026-09-15.

Total Purchases

$20K

2 transactions

Total Sales

—

0 transactions

Companies Traded

2 total filings

Active Since

2026-09-11

Last: 2026-09-15

Companies

TENAX THERAPEUTICS, INC.

Date	Ticker	Type	Shares	Price	Value	Owned After
2026-09-15	TENX	Purchase	4,850	$1.82	$9K	22.2K	SEC ↗
2026-09-11	TENX	Purchase	6,000	$1.88	$11K	17.3K	SEC ↗